The article reports that KOSDAQ-listed BIOBIJOU signed an exclusive partnership with Orthotech and secured the distribution rights for CELIVION, an hADM-based ECM Skin Reviser.
CEO Yang Jun-ho and Vice President Kim Young-je, who leads the ECM business, were reported to have attended the signing ceremony on June 18, 2026.
Plans to expand domestic hospital and clinic channels and to enter overseas markets were mentioned.
Translated from the Korean original. Source article (in Korean): Dealsite




